U.S., April 19 -- ClinicalTrials.gov registry received information related to the study (NCT06375213) titled 'Investigating Neurocognitive Disorders Epidemiology' on April 16.
Brief Summary: This is a prospective cohort study with the main purpose of predicting progression neurocognitive disorders in Thai population. The main predictor variables to be evaluated are plasma phosphorylated tau (p-tau) level and cognitive test scores, which will be combined using statistical/computational modeling. Additionally, it seeks to evaluate biomarkers for diagnosing disease pathologies, understand their correlation with clinical outcomes, and explore the socioeconomic impact of neurocognitive disorders. The study invites both participants for biospeci...